Cargando…
Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors
Chimeric antigen receptor (CAR)-modified T cells have revealed promising results in the treatment of cancer, but they still need to overcome various hurdles, including a complicated manufacturing process. Receptor-targeted lentiviral vectors (LVs) delivering genes selectively to T cell subtypes may...
Autores principales: | Jamali, Arezoo, Kapitza, Laura, Schaser, Thomas, Johnston, Ian C.D., Buchholz, Christian J., Hartmann, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453803/ https://www.ncbi.nlm.nih.gov/pubmed/30997367 http://dx.doi.org/10.1016/j.omtm.2019.03.003 |
Ejemplares similares
-
Lentiviral and adeno-associated vectors efficiently transduce mouse T lymphocytes when targeted to murine CD8
por: Michels, Alexander, et al.
Publicado: (2021) -
CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes
por: Kapitza, Laura, et al.
Publicado: (2023) -
Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics
por: Charitidis, Filippos T., et al.
Publicado: (2021) -
Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics
por: Charitidis, Filippos T., et al.
Publicado: (2022) -
Dasatinib is a potent enhancer for CAR T cell generation by CD3-targeted lentiviral vectors
por: Braun, Angela H., et al.
Publicado: (2022)